BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3613740)

  • 1. [Anticardiolipin antibodies and thrombosis in systemic lupus erythematosus].
    Font J; Casals FJ; Cervera R; Bové A
    Med Clin (Barc); 1987 May; 89(1):41. PubMed ID: 3613740
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesenteric thrombosis associated with anticardiolipin antibodies in a patient with systemic lupus erythematosus.
    Cappell MS; Seibold JR
    Am J Gastroenterol; 1992 Apr; 87(4):520-2. PubMed ID: 1553941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies.
    De Clerck LS; Michielsen PP; Ramael MR; Janssens E; Van Maercke YM; Van Marck EA; Stevens WJ
    J Rheumatol; 1991 Dec; 18(12):1919-21. PubMed ID: 1795332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occlusive vasculopathy in systemic lupus erythematosus. Association with anticardiolipin antibody.
    Greisman SG; Thayaparan RS; Godwin TA; Lockshin MD
    Arch Intern Med; 1991 Feb; 151(2):389-92. PubMed ID: 1992968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A maternal death due to thrombotic disease associated with anticardiolipin antibody.
    Bendon RW; Wilson J; Getahun B; van der Bel-Kahn J
    Arch Pathol Lab Med; 1987 Apr; 111(4):370-2. PubMed ID: 3827544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.
    Harris EN; Gharavi AE; Boey ML; Patel BM; Mackworth-Young CG; Loizou S; Hughes GR
    Lancet; 1983 Nov; 2(8361):1211-4. PubMed ID: 6139567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Libman-Sacks endocarditis and anticardiolipin antibodies].
    Sacanella E; Estruch R; Cervera R; Grau JM
    Med Clin (Barc); 1989 May; 92(18):716-7. PubMed ID: 2755246
    [No Abstract]   [Full Text] [Related]  

  • 8. High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus.
    Mackworth-Young C; Chan J; Harris N; Walport M; Bernstein R; Batchelor R; Hughes G; Gharavi A
    J Rheumatol; 1987 Aug; 14(4):723-6. PubMed ID: 3668978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case from practice (168). Lupus-like syndrome with partial C2 and C4 deficiency - positive anticardiolipin antibodies].
    Müller R
    Schweiz Rundsch Med Prax; 1990 Mar; 79(12):375-6. PubMed ID: 2320809
    [No Abstract]   [Full Text] [Related]  

  • 10. Veno-occlusive disease in systemic lupus erythematosus: possible association with anticardiolipin antibodies?
    Hughes GR; Mackworth-Young C; Harris EN; Gharavi AE
    Arthritis Rheum; 1984 Sep; 27(9):1071. PubMed ID: 6477658
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anticardiolipin antibodies: a new sero-immunologic marker in systemic lupus erythematosus?].
    Scagliusi P; Cafiero S; Silvestris F; Frassanito A; Pipitone V
    Recenti Prog Med; 1987 May; 78(5):230-4. PubMed ID: 3628945
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of antiphospholipid autoantibodies in lupus erythematosus].
    Pozsonyi T; Lakos G; Jakab L; Baraczka K; Jánoskuti L; Kleiber M; Sipka S; Pajor A; Szegedi G
    Orv Hetil; 1998 Oct; 139(40):2363-8. PubMed ID: 9796352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cofactor (beta 2-glycoprotein 1) dependent anticardiolipin antibodies and thrombosis.
    Kaburaki J; Kuwana M; Ikeda Y; Yamamoto M; Kawai S; Matsuura E
    J Rheumatol; 1994 Jul; 21(7):1371-2. PubMed ID: 7966091
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic lupus erythematosus presenting with lingual infarction.
    Korn S; Huppert A; Spitzer S; DeHoratius RJ
    J Rheumatol; 1988 Aug; 15(8):1281-3. PubMed ID: 3184076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
    Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
    Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticardiolipin antibodies in systemic lupus erythematosus and their association with thrombocytopenia].
    Ichikawa Y; Kobayashi N; Watanabe K; Uchiyama M; Shimizu H; Moriuchi J; Takaya M; Arimori S
    Ryumachi; 1988 Apr; 28(2):80-8. PubMed ID: 3406867
    [No Abstract]   [Full Text] [Related]  

  • 19. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
    Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H
    Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
    Rodriguez VE; Gonzalez-Pares EN; Rivera C
    P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.